Spravato Treatment in Denver: FDA-Approved Ketamine Therapy for Treatment-Resistant Depression

When traditional antidepressants have failed to provide relief, Spravato  (esketamine) offers new hope as the first FDA-approved breakthrough treatment for treatment-resistant depression in decades. At Axis Integrated Mental Health, our Spravato specialists in Denver, Boulder, and Westminster provide this innovative nasal spray treatment that can provide rapid relief when other treatments haven’t worked.

Want to know how much Spravato treatments cost in Denver with your insurance coverage?

Book a free financial consultation with a benefits specialist at Axis!

At your appointment, we’ll tell you:

  1. What your insurance plan requires to cover treatment
  2. Your estimated out-of-pocket cost
  3. What you can expect from Spravato treatment including time commitments, when you might to start feeling better, and other options.

We’re here to help you get better, faster, and at the lowest possible out-of-pocket cost! Or get a rough estimate of your total out of pocket cost using our free Spravato cost calculator.

Get a Free Financial Consultation

 

Understanding Spravato: Revolutionary FDA-Approved Treatment

Spravato (esketamine) is a nasal spray medication derived from ketamine that was approved by the FDA in March 2019 for treatment-resistant depression and in August 2020 for major depressive disorder with acute suicidal ideation. This breakthrough represents the first truly novel mechanism for treating depression approved by the FDA in over 30 years.

Unlike traditional antidepressants that target serotonin systems, Spravato works through the brain’s NMDA receptors, triggering rapid changes in neural connectivity that can reverse depression symptoms within hours or days rather than weeks. The medication is administered as a nasal spray in certified healthcare facilities under medical supervision.

How Spravato Works: The Science Behind Rapid Relief

Spravato® works differently than traditional antidepressants by rapidly enhancing your brain’s natural ability to heal, a process known as neuroplasticity. By blocking specific receptors (NMDA), it increases glutamate activity, which is crucial for brain cell communication. This action sparks the immediate growth of new neural connections, literally helping to rebuild and strengthen brain circuits weakened by depression.

The most remarkable part? While the medication is processed by your body in a few hours, the positive changes it initiates in your brain’s wiring can provide lasting relief from symptoms for days to weeks.

Spravato (esketamine) is the only FDA-approved ketamine-based nasal spray for adults with treatment-resistant depression and for major depression with acute suicidal ideation. It works on NMDA receptors to rapidly improve symptoms, often within hours or days, and is administered in a certified clinic under medical supervision.

On treatment day, we check your vitals, you self-administer the nasal spray under supervision, and relax in a private room during a two-hour monitoring period. The schedule begins twice weekly for four weeks, then tapers to weekly and maintenance sessions; you cannot drive afterward and should arrange transportation.

Most major plans — including Anthem BCBS, Aetna, Cigna, and United Healthcare — cover Spravato when criteria are met. Our team verifies benefits, handles prior authorization and appeals, and provides clear cost estimates so you can focus on recovery.

Discover how psilocybin, ketamine, and TMS reshape neuroplasticity to improve mental health in our article.

Proven Effective by Science and Approved by the FDA

Spravato® isn’t just a promising new treatment; it’s an FDA-approved medication backed by extensive clinical research for adults with treatment-resistant depression or those experiencing acute suicidal thoughts. In clinical trials, patients taking Spravato alongside an oral antidepressant showed significantly greater and faster improvement than those who didn’t. The results were compelling: over half of patients with treatment-resistant depression felt meaningful relief, and a third achieved remission after just four weeks. For many, these benefits began within 24-48 hours, providing rapid and life-saving potential for individuals in crisis. With continued, long-term treatment, nearly half of patients maintained their recovery and went into remission.

Your Treatment Journey: Safe, Supervised, and Structured

Because patient safety is the highest priority, Spravato treatment follows strict FDA protocols. It is only available through a safety program called REMS and is administered in a certified healthcare facility like ours. On treatment day, we’ll start with a quick assessment of your blood pressure and mental state. You will then self-administer the nasal spray under our team’s supervision. Afterward, you’ll relax in a private room with zero gravity chair with warming eye masks and a blanket for a two-hour monitoring period to ensure any side effects like dizziness or nausea are managed. Since you cannot drive after treatment, you will need to arrange for transportation home and our free transportation can provide rides if your ride falls through. Your journey begins with twice-weekly treatments for the first month, gradually decreasing in frequency as you feel better, until you settle into a maintenance schedule that sustains your progress.

Is Spravato the Right Choice for You?

Spravato is designed for adults with moderate to severe depression who haven’t found relief after trying at least two different oral antidepressants. It’s an ideal option if your symptoms significantly impact your work, relationships, and daily life despite previous treatments. Spravato is also a powerful intervention for adults with major depression who are experiencing acute suicidal thoughts and need immediate help. In every case, it is used in combination with a daily oral antidepressant. The best candidates are those who are motivated and able to commit to the required treatment schedule and safety protocols.

Understanding Spravato’s Safety and Side Effects

Spravato has a well-established safety profile, though it requires careful supervision due to its unique effects. The most common side effects include a temporary feeling of dissociation (detachment), dizziness, nausea, or a short-term increase in blood pressure. These effects are typically mild and resolve within the two-hour monitoring period following your treatment. To ensure your safety, our highly trained staff monitors your vital signs and mental status throughout the process and is fully equipped to manage any side effects. We also take precautions for those with certain cardiovascular conditions, require drug testing to prevent negative interactions, and also stock our clinic with rescue meds and antiemetics for nausea.

Navigating Insurance for Spravato Treatment

A major advantage of Spravato is its FDA approval, which has resulted in widespread insurance coverage. Most major plans, including Anthem BCBS,  Aetna, Cigna, and United Healthcare, cover the treatment when medical criteria are met. While this usually requires a prior authorization to document your treatment history, our dedicated team handles all the paperwork and any necessary appeals. We will verify your benefits beforehand so you understand any out-of-pocket costs and can focus entirely on your recovery. After years of treating thousands of patients with Spravato, we are experts in getting prior authorizations for Spravato to ensure maximum benefit at minimal cost.

We also offer a free Spravato cost calculator to give you an estimate of what Spravato treatment may cost over the course of the year, taking into account factors like savings card discounts, general insurance plan benefits, and average costs. You can also book a free financial consult with a team member to ask more questions and get a written estimate.

Get Your Spravato Ketamine Therapy Total Estimate

Important: This is an estimate only, not a guarantee or full benefits investigation. Actual costs depend on your specific plan and claim processing. You are not required or encouraged to book services with Axis based upon this calculator. The calculator is provided as a certain mental and behavioral health concerns.

How Spravato Compares to Other Depression Treatments

Spravato stands apart from other treatments in several key ways. Compared to traditional antidepressants, it works much faster — in hours or days, not weeks — and uses a completely different mechanism in the brain, making it effective when others have failed. Unlike IV ketamine, Spravato is FDA-approved specifically for depression, which means it’s covered by insurance and follows standardized, federally mandated safety protocols. And when compared to a non-medication treatment like TMS, Spravato often provides a much quicker response, though the two can be powerfully combined for even better results.

Success Stories: Real Patients, Real Results

Getting Started with Spravato Treatment

Beginning your Spravato treatment is a thoughtful and supportive process designed to ensure your safety, maximize effectiveness, and secure insurance coverage from the very start. Your journey begins with a comprehensive evaluation where we’ll discuss your depression history, current symptoms, and carefully document the past treatments you’ve tried. This detailed review, along with a standard medical clearance, is essential for confirming that Spravato is a safe and appropriate choice for you and is a key step in gaining insurance approval.

While we focus on your clinical needs, our administrative team works in parallel to handle the logistics. We will verify your insurance benefits, manage the entire prior authorization process, and provide you with a clear financial plan outlining any copays or costs so there are no surprises. Before your first session, we’ll sit down with you for an education session to walk you through what to expect, discuss potential side effects, and answer all your questions. We’ll also help you plan the practical details, like arranging transportation home after each appointment, ensuring you feel confident, prepared, and fully supported as you take this important step toward recovery.

Frequently Asked Questions About Spravato Treatment

How effective is Spravato for treatment-resistant depression?

Spravato has demonstrated significant effectiveness for treatment-resistant depression in FDA approval studies. Clinical trials showed that 60-70% of patients with treatment-resistant depression experienced meaningful improvement when Spravato was added to their existing oral antidepressant. The medication works through a completely different mechanism than traditional antidepressants, targeting NMDA receptors rather than serotonin systems. This novel approach allows Spravato to be effective even when multiple previous antidepressants have failed. Response typically occurs within days rather than weeks, with many patients noticing initial improvements within 24-48 hours of treatment. Read our article on “What is the Best Treatment for Depression” to compare Spravato to other treatments like IV Ketamine, Deep TMS, and antidepressants.

What does Spravato treatment feel like?

During Spravato treatment, you’ll self-administer the nasal spray under medical supervision in our treatment facility. The medication may cause temporary side effects including mild dissociation (feeling detached or “floaty”), nausea, dizziness, or sedation. These effects typically peak 15-40 minutes after administration and gradually resolve over 2 hours. Many patients find the experience tolerable and even relaxing. You’ll remain conscious and able to communicate with staff throughout treatment. The 2-hour monitoring period allows any side effects to resolve before you go home. Transportation must be arranged as you cannot drive after treatment.

Does insurance cover Spravato treatment in Denver?

Many people wonder if ketamine therapy is covered by insurance. Most major insurance plans cover Spravato treatment for FDA-approved indications. We take insurance plans like Aetna, Anthem, Cigna, and United Healthcare and they typically cover treatment when medical criteria are met. Coverage requires documentation of treatment-resistant depression (failed trials of at least 2 antidepressants) and must be provided at REMS-certified facilities. Prior authorization is usually required but approval rates are high when criteria are met. Our insurance team handles all prior authorization paperwork and appeals to maximize your coverage. Unlike off-label ketamine treatment, Spravato’s FDA approval makes insurance coverage much more straightforward.

How often do I need Spravato treatments?

Spravato treatment follows an FDA-mandated schedule that starts with twice-weekly treatments for the first 4 weeks (induction phase), then weekly treatments for weeks 5-8 (optimization phase). After the initial 8 weeks, treatment frequency is individualized based on your response, ranging from weekly to monthly maintenance treatments. Most patients require ongoing treatment to maintain benefits, though the frequency often decreases over time as symptoms stabilize. The treatment schedule is designed to build and maintain the neuroplasticity changes that provide antidepressant benefits. Your psychiatric provider will work with you to find the optimal maintenance schedule.

Will I still be considered sober if I try ketamine therapy?

This is a common concern for people in recovery. Because some people abuse ketamine recreationally, they are afraid that a medical treatment delivered in a controlled, clinical setting is equivalent and may put sobriety at risk. We can’t generalize, but we can say that based on our experience treating thousands of patients, many of whom have had a substance abuse history in the past, sobriety is more than possible. But it depends on any individual’s recovery stability, how the treatment is structured, and whether it is clinically appropriate for you. These are all things we consider when our providers evaluate treatments for patients.

At Axis Integrated Mental Health, patient safety and long-term recovery come first. That’s why there is a clear requirement: patients must be sober for at least 6 months before starting ketamine-based treatments like Spravato. This helps ensure that:

  • The treatment does not interfere with early recovery
  • There is a stable baseline to accurately assess outcomes
  • The risk of misuse or psychological destabilization is minimized

The goal is to treat conditions like depression, not to create an altered state for its own sake. Many patients in stable recovery are able to go through treatment without compromising their sobriety, especially when it is part of a structured, medically supervised plan.

That said, your concern is valid, and for some people, even the idea of using a dissociative medication can feel uncomfortable or triggering. If maintaining strict sobriety without any exposure to substances is important to you, Transcranial Magnetic Stimulation (TMS) may be a better fit. TMS:

The right answer depends on your history, your recovery goals, and your comfort level. A good provider will help you weigh options carefully, not push you into one path.The good news is that we offer both Deep TMS and Spravato at all of our facilities, so you can make the decision that’s right for you.

Transform Your Life with FDA-Approved Spravato Treatment

If you’ve struggled with treatment-resistant depression despite trying multiple antidepressants, Spravato offers genuine hope for rapid, meaningful improvement. This FDA-approved breakthrough treatment has helped thousands of people reclaim their lives when traditional medications failed to provide relief.

At Axis Integrated Mental Health, our Spravato specialists provide safe, expert care using FDA-mandated protocols in our REMS-certified facilities. We understand the frustration of failed treatments and are committed to helping you achieve the rapid relief you deserve through this innovative, well-researched therapy. Check out our new patient information center to learn what our patients have to say about getting Spravato treatments at Axis Integrated Mental Health and what you can do to prepare for treatment.

Don’t let treatment-resistant depression control your future. Spravato’s unique mechanism and rapid onset can provide the breakthrough you’ve been seeking, offering real hope for sustained recovery and improved quality of life within days, not months.

Ready to explore FDA-approved Spravato treatment? Breakthrough depression relief is available.

Schedule with a pscyhiatric provider online at axismh.com/book-online or call/text our Denver office at 720.400.7025 to speak with our benefits specialists about your treatment eligibility and insurance coverage for this life-changing therapy.